Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,587 | -5,633 | -25,997 | -17,941 | -10,643 |
| Depreciation Amortization | 230 | 120 | 542 | 406 | 268 |
| Accounts receivable | -17 | -123 | N/A | 0 | N/A |
| Accounts payable and accrued liabilities | -432 | -188 | 368 | 324 | 199 |
| Other Working Capital | -3,576 | -2,569 | 2,626 | 920 | -353 |
| Other Operating Activity | 1,862 | 1,022 | 2,526 | 1,770 | 1,197 |
| Operating Cash Flow | $-12,519 | $-7,371 | $-19,935 | $-14,523 | $-9,333 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -1,008 | -3,008 | 0 |
| PPE Investments | -52 | -48 | -252 | -239 | -221 |
| Other Investing Activity | 0 | 0 | 6,327 | 6,327 | 6,327 |
| Investing Cash Flow | $-52 | $-48 | $5,067 | $3,080 | $6,106 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 5,348 | N/A | N/A | 0 | N/A |
| Common Stock Issued | 6,457 | 13 | 14,652 | 14,642 | 13 |
| Other Financing Activity | -1,171 | -564 | -2,136 | -1,602 | -413 |
| Financing Cash Flow | $10,634 | $-550 | $12,516 | $13,041 | $-400 |
| Beginning Cash Position | 28,488 | 28,488 | 30,841 | 30,841 | 30,841 |
| End Cash Position | 26,551 | 20,518 | 28,488 | 32,439 | 27,214 |
| Net Cash Flow | $-1,937 | $-7,969 | $-2,353 | $1,598 | $-3,627 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,519 | -7,371 | -19,935 | -14,523 | -9,333 |
| Capital Expenditure | -52 | -48 | -252 | -239 | -221 |
| Free Cash Flow | -12,571 | -7,419 | -20,188 | -14,762 | -9,554 |